John H. van Drie
11Patents
5h-index
18Co-inventors
59Inventor score
Filing activity: Jul 11, 2002 → Nov 19, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7273885B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | Chemistry; Metallurgy | 44 | Expired |
| US6909000B2 | Bridged bicyclic serine protease inhibitors | Human Necessities | 40 | Expired |
| US7241796B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | Human Necessities | 25 | Expired |
| US7378422B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | Human Necessities | 22 | Expired |
| US9771366B2 | Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazine-2-carboxamides as RSK inhibitors | Chemistry; Metallurgy | 6 | Active |
| US7745444B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | Human Necessities | 3 | Active |
| US10081632B2 | Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-α]pyrazine-2-carboxamides as RSK inhibitors | Chemistry; Metallurgy | 2 | Active |
| US8217048B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | Human Necessities | 1 | Active |
| US10758530B2 | Carboxamide derivatives useful as rsk inhibitors | Chemistry; Metallurgy | 1 | Active |
| US12209092B2 | Inhibitors of GLI1 as therapeutic agents | Chemistry; Metallurgy | 0 | Active |
| US8486989B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.